Evidence map›Paper›PMID 39825229›Full record

ArticleBMC infectious diseases2025

The incidence of radiologically verified community-acquired pneumonia requiring hospitalisation in adults living in southern Sweden, 2016-2018: a population-based study.

Elisabeth Rünow, Frida Valeur, Gustav Torisson, Karin Hansen, Christian Theilacker, Kristian Riesbeck, Jonas Ahl

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elisabeth RünowClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, SE21428, Malmö, Sweden.
Frida ValeurInfectious Diseases, Department of Translational Medicine, Faculty of Medicine, Lund University, SE21428, Malmö, Sweden.
Gustav TorissonInfectious Diseases, Department of Translational Medicine, Faculty of Medicine, Lund University, SE21428, Malmö, Sweden.
Karin HansenClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, SE21428, Malmö, Sweden.
Christian TheilackerVaccines Global Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, USA.
Kristian RiesbeckClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, SE21428, Malmö, Sweden.
Jonas AhlClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, SE21428, Malmö, Sweden. jonas.ahl@med.lu.se.

Funding

Forssman's Foundation) KHKnut and Alice Wallenberg Foundation KR 2018.0318Swedish Heart Lung Foundation KR 20180401Swedish Research Council KR 2019-01053the Royal Physiographical Society KHthe Skåne County Council's research and development foundation KR
6 · The paper itself

Abstract

backgroundCommunity-acquired pneumonia (CAP) was one of the most common causes of death in the European Union in 2017. Severity and mortality of CAP increase with age and an aging European population will require increased planning for prevention, control, and management of CAP. The purpose of this study was to provide an updated population-based estimate of the incidence of CAP requiring hospitalization in Northern Europe.

methodWe conducted a retrospective cohort study estimating the population-based incidence of CAP requiring hospitalization. Adults residing in Southern Sweden admitted between September 2016 and September 2018 with radiographically confirmed CAP and a primary discharge diagnosis consistent with pneumonia were identified by retrospective medical chart review. Incidence rates were stratified by age and sex.

resultsWe identified 1,575 episodes of CAP in 1,471 unique individuals, accounting for 45% of the total eligible patient population. The crude incidence rate of CAP requiring hospitalization was 259 (95% CI: 246-272) and age-standardized rate was 294 (95% CI: 280-309) per 100,000 person-years. Among those aged 80 years and older, hospitalization rate was 17 times higher vs those aged 18-64 years, yielding an IRR 17.4 (95% CI: 15.4-19.7). Males aged ≥ 80 years had a 57% increased risk of CAP requiring hospitalization compared to women ≥ 80 years, resulting in an IRR of 1.57 (95% CI: 1.33-1.85). The lowest in-hospital case-fatality risk was among the 18-64 years group 3.4% (n = 16), and highest among those ≥ 80 years 8.1% (n = 46).

conclusionWe found that the incidence and mortality of CAP requiring hospitalization in adults are considerable. Preventive measures are needed that target older adults and those at increased risk of CAP.

Indexed as

Community-Acquired InfectionsHospitalizationPneumoniaAdolescentAdultAgedAged, 80 and overCommunity-Acquired PneumoniaFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesSwedenYoung AdultAgeCAPCommunity acquired pneumoniaEpidemiologyIncidenceMortalityStreptococcus pneumoniaeVaccination

Identifiers

PMID39825229
PMCPMC11742510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.